Citation: | JIA Chunyu, WANG Gangan, WANG Jiahui, CHEN Gang, ZHENG Ke, LI Xuemei. Correlation Between Neutrophil to Lymphocyte Ratio and eGFR in Diabetic Patients: A Cross-sectional Analysis Based on NHANES Data[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(2): 379-385. DOI: 10.12290/xhyxzz.2024-0908 |
To investigate the association between neutrophil to lymphocyte ratio (NLR) andestimated glomerular filtration rate (eGFR) in patients with diabetes using large-scale data.
Across-sectional analysis was conducted using data from diabetic patients in the National Health and Nutrition Examination Survey database from 2009 to 2014. Differences in NLR between patients with and without chronickidney disease (CKD) were compared. Pearson correlation analysis and multiple linear regression models wereapplied to assess the relationship between NLR and eGFR.
A total of 857 diabetic patients were included, with 190 (22.2%) having CKD and 667 (77.8%) without CKD. NLR was significantly higher in patients with CKD compared to those without CKD (2.94±1.69 vs.2.36±1.98, P < 0.001), while eGFR wassignificantly lower[(43.54± 12.79) mL/(min· 1.73 m2) vs.(92.50± 18.20) mL/(min· 1.73 m2), P < 0.001]. Quartile analysis revealed a progressive decline in eGFR with increasing NLR[Q1:(87.05 ±24.93) mL/(min· 1.73 m2);Q2:(83.68 ± 24.98) mL/(min· 1.73 m2);Q3:(83.10 ± 26.26) mL/(min· 1.73 m2);Q4:(72.55 ± 28.15) mL/(min · 1.73 m2);P < 0.001]. Pearson correlation analysisshowed a weak negative relationship between NLR and eGFR (r=-0.15, P < 0.001). After adjusting for confounders, multiple linear regression demonstrated an independent negative association between NLR and eGFR(OR=0.403, 95% CI: 0.210-0.772, P=0.006).
NLR is independently negatively associatedwith eGFR in diabetic patients, demonstrating potential clinical value as an indicator of kidney function declineand CKD risk in this population.
[1] |
Oyewole O O, Ale A O, Ogunlana M O, et al. Burden of disability in type 2 diabetes mellitus and the moderating effects of physical activity[J]. World J Clin Cases, 2023, 11(14): 3128-3139. DOI: 10.12998/wjcc.v11.i14.3128
|
[2] |
Thomas M C, Brownlee M, Susztak K, et al. Diabetic kidney disease[J]. Nat Rev Dis Primers, 2015, 1: 15018. DOI: 10.1038/nrdp.2015.18
|
[3] |
Thomas M C, Cooper M E, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease[J]. Nat Rev Nephrol, 2016, 12(2): 73-81. DOI: 10.1038/nrneph.2015.173
|
[4] |
Mihai S, Codrici E, Popescu I D, et al. Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome[J]. J Immunol Res, 2018, 2018: 2180373. http://downloads.hindawi.com/journals/jir/2018/2180373.pdf
|
[5] |
Eustace J A, Astor B, Muntner P M, et al. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease[J]. Kidney Int, 2004, 65(3): 1031-1040. DOI: 10.1111/j.1523-1755.2004.00481.x
|
[6] |
Gupta J, Mitra N, Kanetsky P A, et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC[J]. Clin J Am Soc Nephrol, 2012, 7(12): 1938-1946. DOI: 10.2215/CJN.03500412
|
[7] |
Sproston N R, Ashworth J J. Role of C-reactive protein at sites of inflammation and infection[J]. Front Immunol, 2018, 9: 754. DOI: 10.3389/fimmu.2018.00754
|
[8] |
Reddy V K K, Shiddapur G, Jagdale N, et al. Investigating interleukin-6 levels in type 2 diabetes mellitus patients with and without diabetic nephropathy[J]. Cureus, 2024, 16(8): e67014.
|
[9] |
Mai M F, Jiang Y L, Wu X M, et al. Association of TGF-β1, IL-4, and IL-10 polymorphisms with chronic kidney disease susceptibility: a meta-analysis[J]. Front Genet, 2020, 11: 79. DOI: 10.3389/fgene.2020.00079
|
[10] |
Li J X, Chen J Z, Lan H Y, et al. Role of C-reactive protein in kidney diseases[J]. Kidney Dis (Basel), 2023, 9(2): 73-81. DOI: 10.1159/000528693
|
[11] |
Cervoni J P, Thévenot T, Weil D, et al. C-reactive protein predicts short-term mortality in patients with cirrhosis[J]. J Hepatol, 2012, 56(6): 1299-1304. DOI: 10.1016/j.jhep.2011.12.030
|
[12] |
Buonacera A, Stancanelli B, Colaci M, et al. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases[J]. Int J Mol Sci, 2022, 23(7): 3636. DOI: 10.3390/ijms23073636
|
[13] |
Azab B, Chainani V, Shah N, et al. Neutrophil-lymphocyte ratio as a predictor of major adverse cardiac events among diabetic population: a 4-year follow-up study[J]. Angiology, 2013, 64(6): 456-465. DOI: 10.1177/0003319712455216
|
[14] |
Levey A S, Inker L A, Coresh J. GFR estimation: from physiology to public health[J]. Am J Kidney Dis, 2014, 63(5): 820-834. DOI: 10.1053/j.ajkd.2013.12.006
|
[15] |
Webster A C, Nagler E V, Morton R L, et al. Chronic kidney disease[J]. Lancet, 2017, 389(10075): 1238-1252. DOI: 10.1016/S0140-6736(16)32064-5
|
[16] |
Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives[J]. Bratisl Lek Listy, 2021, 122(7): 474-488. http://www.zhangqiaokeyan.com/journal-foreign-detail/0704078175096.html
|
[17] |
Templeton A J, McNamara M G, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and Meta-analysis[J]. J Natl Cancer Inst, 2014, 106(6): dju124. DOI: 10.1186%2Fs13058-016-0794-1.pdf
|
[18] |
Moisa E, Corneci D, Negoita S, et al. Dynamic changes of the neutrophil-to-lymphocyte ratio, systemic inflammation index, and derived neutrophil-to-lymphocyte ratio independently predict invasive mechanical ventilation need and death in critically ill COVID-19 patients[J]. Biomedicines, 2021, 9(11): 1656. DOI: 10.3390/biomedicines9111656
|
[19] |
Regolo M, Vaccaro M, Sorce A, et al. Neutrophil-to-lym-phocyte ratio (NLR) is a promising predictor of mortality and admission to intensive care unit of COVID-19 patients [J]. J Clin Med, 2022, 11(8): 2235. DOI: 10.3390/jcm11082235
|
[20] |
Li X M, Liu C, Mao Z, et al. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and Metaanalysis[J]. Crit Care, 2020, 24(1): 647. DOI: 10.1186/s13054-020-03374-8
|
[21] |
Li Q Q, Chen P, Shi S F, et al. Neutrophil-to-lymphocyte ratio as an independent inflammatory indicator of poor prognosis in IgA nephropathy[J]. Int Immunopharmacol, 2020, 87: 106811. DOI: 10.1016/j.intimp.2020.106811
|
[22] |
Gok M. Evaluation of the relationship between the mean platelet volume and the neutrophil/lymphocyte ratio with progression of chronic kidney disease in patients with autosomal dominant polycystic kidney disease[J]. North Clin Istanb, 2022, 9(4): 317-322.
|
[23] |
Ao G Y, Wang Y S, Qi X, et al. Association of neutrophil-to-lymphocyte ratio and risk of cardiovascular or all-cause mortality in chronic kidney disease: a meta-analysis[J]. Clin Exp Nephrol, 2021, 25(2): 157-165. DOI: 10.1007/s10157-020-01975-9
|
[24] |
Zheng F F, Ma L Q, Li X, et al. Neutrophil extracellular traps induce glomerular endothelial cell dysfunction and pyroptosis in diabetic kidney disease[J]. Diabetes, 2022, 71(12): 2739-2750. DOI: 10.2337/db22-0153
|
[25] |
Zheng Z H, Zheng F. Immune cells and inflammation in diabetic nephropathy[J]. J Diabetes Res, 2016, 2016: 1841690. http://www.onacademic.com/detail/journal_1000040476219810_fe25.html
|
[26] |
Lim A K H, Tesch G H. Inflammation in diabetic nephropathy[J]. Mediators Inflamm, 2012, 2012: 146154.
|
[27] |
Winter L, Wong L A, Jerums G, et al. Use of readily accessible inflammatory markers to predict diabetic kidney disease [J]. Front Endocrinol (Lausanne), 2018, 9: 225. DOI: 10.3389/fendo.2018.00225
|
[28] |
Qin W D, Sun L, Dong M, et al. Regulatory T cells and diabetes mellitus[J]. Hum Gene Ther, 2021, 32(17/18): 875-881. http://pubmed.ncbi.nlm.nih.gov/33975439/
|
[29] |
Lee J S, Kim N Y, Na S H, et al. Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea[J]. Medicine (Baltimore), 2018, 97(26): e11138. DOI: 10.1097/MD.0000000000011138
|